Overview
Viable CD34 cells are an important population of hematopoietic stem and progenitor cells used in transplantation and regenerative medicine. After collection, both the CD34 count and cell viability are assessed to evaluate the quality of harvested cells. These parameters help determine whether the collected cells are sufficient for successful engraftment.
CD34 is a surface marker present on early hematopoietic stem cells. These cells play a critical role in bone marrow transplantation because of their ability to reconstitute the hematopoietic system. Measurement of viable CD34 cells is commonly performed in donors to assess suitability for transplantation.
CD34-positive lymphohaematopoietic stem cells possess the ability to regenerate and maintain blood cell production. This property also allows their use in therapeutic applications, including the treatment of ischemic conditions.
Functions
CD34-positive hematopoietic progenitor cells are usually isolated from peripheral blood following apheresis. After transplantation, these cells are capable of differentiating into multiple cell types. These include fibroblasts, osteoblasts, chondrocytes, myocytes, adipocytes, and endothelial cells.
Cell viability refers to the proportion of healthy, living cells within a sample. Viability is a crucial indicator for understanding cell survival, proliferation, and response to external factors. It is especially important in transplantation settings where only viable cells contribute to engraftment.
These cells exhibit multipotency, meaning they can give rise to various mature blood cells such as leukocytes, erythrocytes, and platelets. Their regenerative capacity allows continuous replenishment of the hematopoietic system.
Indications
Assessment of viable CD34 cells is primarily used to monitor the quality of harvested stem cells. This evaluation ensures that the collected sample meets the required standards for clinical use.
The test also provides an indication of whether the collected cell dose is sufficient for successful engraftment. If the yield is inadequate, the procedure may be repeated until a clinically significant number of viable cells is achieved.
Methods of Estimation
Flow cytometry combined with viability testing is the most commonly used method for estimating viable CD34 cells. This technique allows accurate identification and quantification of CD34-positive cells while simultaneously assessing cell viability.
Another method used is the colony-forming unit assay. This assay helps determine the presence of viable progenitor cells based on their ability to proliferate and form colonies under suitable conditions.
Sample Collection
Peripheral blood, bone marrow, and cord blood are the preferred sample types for analysis of viable CD34 cells. These sources provide an adequate number of stem cells for assessment.
Approximately 3.0 ml of the sample is collected in a K3EDTA tube and should be sent to the laboratory urgently. Proper anticoagulation and timely processing are essential to maintain cell integrity.
For optimal results, samples should be refrigerated. During transportation, the temperature should be maintained at around 4°C to preserve cell viability.
Separation of CD34 Cells
CD34 positive cells are separated using immunomagnetic techniques. In this process, the cell suspension is labeled with antibodies specific to CD34 and placed in a magnetic device.
Unwanted CD34-negative cells are removed, while the desired CD34-positive cells remain in the tube. This method ensures high purity and viability of isolated stem cells.
Adult stem cells require specific harvesting techniques such as aspiration and tissue dissection. These methods differ from embryonic stem cell isolation, which involves separation from the inner cell mass of blastocysts.
Sample Preparation
For analysis, specific antibodies such as Anti-CD45 and Anti-CD34 are added to a polystyrene tube. A viability dye is also included to distinguish live cells from dead cells.
A measured volume of well-mixed cell sample is added to the tube. The mixture is incubated for a fixed duration under protected conditions to prevent light exposure.
This preparation allows accurate identification of viable CD34-positive cells during flow cytometric analysis.
Reference Interval
The reference interval for absolute viable CD34 cells ranges from 3.50 to 66.10 cells per microliter, with a median value of 16.81 cells per microliter.
The reference range for relative counts of CD34-positive cells varies between 0.09 and 0.99, with a median of 0.34. These values help in interpreting test results and assessing the adequacy of stem cell collections.
Prognostic Significance
An increased percentage of myeloid CD34-positive cells in bone marrow is associated with a better prognosis in certain hematological disorders. In contrast, elevated circulating CD34 cells may indicate adverse outcomes in myelodysplastic syndromes.
In healthy donors, CD34-positive cells constitute a small fraction of circulating nucleated cells, while bone marrow shows significantly higher percentages. If levels are low, mobilization of stem cells from bone marrow into peripheral blood may be required using appropriate medications.
